| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 170.27B | 158.75B | 173.01B | 172.49B | 151.67B | 116.52B |
| Gross Profit | 8.35B | 8.80B | 8.15B | 7.68B | 7.38B | 7.16B |
| EBITDA | 2.78B | 2.87B | 2.82B | 2.85B | 2.69B | 2.79B |
| Net Income | 1.97B | 2.10B | 1.99B | 1.95B | 1.78B | 1.89B |
Balance Sheet | ||||||
| Total Assets | 84.28B | 83.64B | 87.86B | 91.53B | 88.54B | 75.10B |
| Cash, Cash Equivalents and Short-Term Investments | 4.82B | 9.04B | 5.29B | 3.08B | 2.95B | 2.89B |
| Total Debt | 31.00B | 28.80B | 31.74B | 34.07B | 35.67B | 28.11B |
| Total Liabilities | 52.65B | 50.25B | 56.16B | 61.96B | 62.04B | 49.33B |
| Stockholders Equity | 31.63B | 33.39B | 31.70B | 29.57B | 26.50B | 25.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.80B | 4.62B | 4.88B | -6.56B | -11.58B |
| Operating Cash Flow | 0.00 | 7.49B | 4.67B | 4.96B | -6.48B | -11.38B |
| Investing Cash Flow | 0.00 | -1.16B | -35.02M | -96.52M | -92.13M | -169.65M |
| Financing Cash Flow | 0.00 | -3.07B | -2.42B | -4.74B | 6.64B | 7.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥46.11B | 6.29 | ― | 6.31% | -12.17% | -23.60% | |
67 Neutral | ¥30.47B | 8.82 | ― | 4.13% | -3.15% | 29.33% | |
66 Neutral | ¥39.13B | 8.84 | ― | 6.27% | -6.54% | -28.89% | |
65 Neutral | ¥65.48B | 9.27 | ― | 5.15% | -12.34% | -36.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥18.58B | 10.08 | ― | 5.36% | -8.24% | 0.67% | |
55 Neutral | ¥35.35B | 13.50 | ― | 5.02% | -12.42% | -56.79% |